The part of your hormone cycle nobody explains

You probably know estrogen is produced in the ovaries. You probably know it affects your cycle, your skin, your mood, your bone density. What almost nobody explains is what happens to estrogen after it's been used.

Used estrogen travels to the liver, where it's chemically deactivated and conjugated (attached to a molecule that makes it water-soluble and ready for elimination). It's then shipped to the gut for excretion. Here's where it gets complicated: some gut bacteria intercept it. They produce an enzyme called beta-glucuronidase that snips off the conjugated molecule and frees the estrogen. That freed estrogen is reabsorbed through the gut wall, re-enters circulation, and acts on your body again.

This recycling loop is the estrobolome. And whether it works efficiently, over-enthusiastically, or sluggishly depends on the composition of your gut microbiome.

Beta-G
Beta-glucuronidase — the bacterial enzyme at the center of the estrobolome. When estrobolome bacteria are diverse and balanced, beta-G activity is calibrated. When dysbiosis reduces diversity, activity can swing significantly in either direction
Dysbiosis
The most common estrobolome disruptor. Antibiotics, highly processed food, chronic psychological stress, and low dietary fiber all reduce microbial diversity — and with it, the regulatory capacity of the estrobolome
Both ways
Estrobolome disruption can push estrogen either higher (if beta-G is overactive, more estrogen is recycled back into circulation) or lower (if bacteria are depleted, less estrogen is recovered and more is eliminated)

What happens when the estrobolome is disrupted

High beta-glucuronidase activity — from a dysbiotic microbiome overrepresented in certain Bacteroides and Firmicutes species — means more estrogen is reclaimed from the gut. Circulating estrogen stays elevated beyond what ovarian production alone would produce. This is one plausible mechanism behind estrogen dominance in women who don't have obviously elevated hormone levels on a blood panel taken in the morning fasted: the recycling system is contributing to a burden that a single snapshot misses.

In this scenario, conditions driven by estrogen excess may worsen: endometriosis, uterine fibroids, estrogen-receptor-positive breast cancer risk, PMS, and PCOS where estrogen dominance is a feature. The 2016 Kwa et al. analysis in Oncotarget drew this connection explicitly for breast cancer risk — noting that gut microbiome composition affects circulating estrogen levels through the estrobolome, and that this mechanism is independent of ovarian function.

Research note

A 2017 review by Baker et al. in Trends in Endocrinology and Metabolism mapped the estrobolome's role across women's health conditions. The authors noted that postmenopausal women had measurably lower urinary estrogen excretion when their gut microbiome diversity was lower — suggesting the estrobolome becomes more influential for estrogen levels post-menopause when ovarian production has dropped significantly. The gut becomes, in effect, a larger relative source of systemic estrogen in this life stage. This has implications for HRT response variability and for why two women with similar hormone prescriptions may have very different clinical responses.

What can actually shift the estrobolome

The honest picture here is that this is an emerging area. The estrobolome concept is scientifically robust; the clinical interventions are still being characterized.

What we can say with confidence: dietary fiber consistently supports microbial diversity. A diverse microbiome is associated with more calibrated estrobolome activity. The specific fiber target in microbiome research is 30+ different plant foods per week — variety matters more than quantity from a single source.

Cruciferous vegetables (broccoli, Brussels sprouts, cabbage, kale) contain a compound called diindolylmethane (DIM) and its precursor indole-3-carbinol (I3C). DIM supports what's called "favorable" estrogen metabolism — promoting the conversion of estradiol into less potent estrogen metabolites. This pathway is distinct from the estrobolome but adjacent: it affects how estrogen is processed upstream of the gut.

Fermented foods (yogurt, kefir, kimchi, sauerkraut) support Lactobacillus populations, which research has associated with more regulated estrobolome activity. The evidence is correlational rather than causal in most studies.

Targeted probiotic supplementation for estrobolome support is an area of active research. Some Lactobacillus strains appear to modulate beta-glucuronidase activity, but specific clinical-grade recommendations don't yet exist. The research is directionally interesting, not yet prescriptive.

What to tell your doctor

🦺

On what this doesn't explain

The estrobolome is a real mechanism with real research behind it. But it's also an area where wellness marketing has raced ahead of clinical evidence — selling probiotic supplements and gut protocols as estrogen regulators when the actual intervention studies are small and early. The most defensible actions are the ones with robust evidence for gut health generally: fiber, diversity, fermented foods, limited antibiotic use. Beyond that, we're in hypothesis territory, not established clinical pathways.

Medical Disclaimer: This article is for informational and educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

References

  1. Kwa M, et al. The intestinal microbiome and estrogen receptor-positive female breast cancer. Oncotarget. 2016;7(37):60242–60253. doi:10.18632/oncotarget.11132
  2. Baker JM, et al. Estrogen-gut microbiome axis: physiological and clinical implications. Maturitas. 2017;103:45–53. doi:10.1016/j.maturitas.2017.06.025
  3. Plottel CS, Blaser MJ. Microbiome and malignancy. Cell Host and Microbe. 2011;10(4):324–335. doi:10.1016/j.chom.2011.10.003
  4. Pernigoni N, et al. Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis. Science. 2021;374(6564):216–224.
  5. Sonnenburg JL, Backhed F. Diet-microbiota interactions as moderators of human metabolism. Nature. 2016;535(7610):56–64. doi:10.1038/nature18846